| breast cancer - triple negative | ||||||
| mBC - Triple negative (TNBC) - (neo)adjuvant (NA) | mBC - Triple negative (TNBC) - 1st Line (L1) | la/mBC - TNBC - L2 - all population | la/mBC - TNBC - L2 - PDL1 positive | es-BC - Triple negatif (TNBC) - (neo)adjuvant (NA) | es-BC - TNBC - NA - all population | |
| chemotherapy | ||||||
| non platinum-based chemotherapy | ||||||
| nucleoside analogues (pyrimidine/purine) | ||||||
| gemcitabine | IMpassion-132 ... IMpassion-132 ... | IMpassion-132 ... IMpassion-132 ... | ||||
| taxanes | ||||||
| docetaxel | BCTOP-T-A01 arm A/B | |||||
| paclitaxel | ||||||
| nab-paclitaxel | FUTURE-SUPER_immunomodulatory subtype | GeparNuevo | ||||
| pegylated liposomal doxorubicin and cyclophosphamide | NSABP B-59/GBG 96-GeparDouze NSABP B-59/GBG 96-GeparDouze | Alice | IMpassion-031 ... ALEXANDRA/IMpassion-030 IMpassion-031 ... | |||
| platinum-based chemotherapy | ||||||
| platinum derivate | ||||||
| carboplatin | NSABP B-59/GBG 96-GeparDouze NSABP B-59/GBG 96-GeparDouze | TBCRC IMpassion-132 ... IMpassion-132 ... | IMpassion-132 ... IMpassion-132 ... | |||
| platinum association | ||||||
| gemcitabine plus platin | BCTOP-T-A01 arm A/B | |||||
Study type:
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
